ID   LSS_RAT                 Reviewed;         733 AA.
AC   P48450; Q62811;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   29-MAR-2005, sequence version 2.
DT   24-JUL-2024, entry version 149.
DE   RecName: Full=Lanosterol synthase;
DE            EC=5.4.99.7 {ECO:0000269|PubMed:7568116};
DE   AltName: Full=2,3-epoxysqualene--lanosterol cyclase;
DE   AltName: Full=Oxidosqualene--lanosterol cyclase;
DE            Short=OSC;
GN   Name=Lss; Synonyms=Osc;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 129-154; 279-287 AND
RP   439-470, FUNCTION, AND CATALYTIC ACTIVITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=7568116; DOI=10.1073/pnas.92.20.9274;
RA   Abe I., Prestwich G.D.;
RT   "Molecular cloning, characterization, and functional expression of rat
RT   oxidosqualene cyclase cDNA.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:9274-9278(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=7735243; DOI=10.1248/bpb.18.195;
RA   Kusano M., Shibuya M., Sankawa U., Ebizuka Y.;
RT   "Molecular cloning of cDNA encoding rat 2,3-oxidosqualene: lanosterol
RT   cyclase.";
RL   Biol. Pharm. Bull. 18:195-197(1995).
RN   [3]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=16440058; DOI=10.1172/jci20797;
RA   Mori M., Li G., Abe I., Nakayama J., Guo Z., Sawashita J., Ugawa T.,
RA   Nishizono S., Serikawa T., Higuchi K., Shumiya S.;
RT   "Lanosterol synthase mutations cause cholesterol deficiency-associated
RT   cataracts in the Shumiya cataract rat.";
RL   J. Clin. Invest. 116:395-404(2006).
CC   -!- FUNCTION: Key enzyme in the cholesterol biosynthesis pathway. Catalyzes
CC       the cyclization of (S)-2,3 oxidosqualene to lanosterol, a reaction that
CC       forms the sterol nucleus (PubMed:7568116). Through the production of
CC       lanosterol may regulate lens protein aggregation and increase
CC       transparency (By similarity). {ECO:0000250|UniProtKB:P48449,
CC       ECO:0000269|PubMed:7568116}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-2,3-epoxysqualene = lanosterol; Xref=Rhea:RHEA:14621,
CC         ChEBI:CHEBI:15441, ChEBI:CHEBI:16521; EC=5.4.99.7;
CC         Evidence={ECO:0000269|PubMed:7568116};
CC   -!- PATHWAY: Terpene metabolism; lanosterol biosynthesis; lanosterol from
CC       farnesyl diphosphate: step 3/3.
CC   -!- SUBUNIT: Monomer. {ECO:0000250|UniProtKB:P48449}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:P48449}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:P48449}.
CC   -!- DISRUPTION PHENOTYPE: Hypomorphic mutations in this gene and the Fdft1
CC       gene were identified, as well as a null mutation in this gene. Cataract
CC       onset is associated with the specific combination of Lss and Fdft1
CC       mutant alleles that decrease cholesterol levels in cataractous lenses
CC       to about 57% of normal. Cholesterol insufficiency may cause the
CC       deficient proliferation of lens epithelial cells in Shumiya cataract
CC       rats, resulting in the loss of homeostatic epithelial cell control of
CC       the underlying fiber cells and ultimately cataractogenesis.
CC       {ECO:0000269|PubMed:16440058}.
CC   -!- SIMILARITY: Belongs to the terpene cyclase/mutase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U31352; AAA91023.1; -; mRNA.
DR   EMBL; D45252; BAA08208.1; -; mRNA.
DR   RefSeq; NP_112311.1; NM_031049.1.
DR   AlphaFoldDB; P48450; -.
DR   SMR; P48450; -.
DR   BioGRID; 249578; 1.
DR   STRING; 10116.ENSRNOP00000069432; -.
DR   BindingDB; P48450; -.
DR   ChEMBL; CHEMBL3262; -.
DR   GuidetoPHARMACOLOGY; 2434; -.
DR   iPTMnet; P48450; -.
DR   PhosphoSitePlus; P48450; -.
DR   jPOST; P48450; -.
DR   PaxDb; 10116-ENSRNOP00000039946; -.
DR   GeneID; 81681; -.
DR   KEGG; rno:81681; -.
DR   UCSC; RGD:620955; rat.
DR   AGR; RGD:620955; -.
DR   CTD; 4047; -.
DR   RGD; 620955; Lss.
DR   eggNOG; KOG0497; Eukaryota.
DR   InParanoid; P48450; -.
DR   OrthoDB; 2712461at2759; -.
DR   PhylomeDB; P48450; -.
DR   BRENDA; 5.4.99.7; 5301.
DR   Reactome; R-RNO-191273; Cholesterol biosynthesis.
DR   SABIO-RK; P48450; -.
DR   UniPathway; UPA00767; UER00753.
DR   PRO; PR:P48450; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0005811; C:lipid droplet; ISO:RGD.
DR   GO; GO:0000250; F:lanosterol synthase activity; IDA:UniProtKB.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0031647; P:regulation of protein stability; ISO:RGD.
DR   GO; GO:0006694; P:steroid biosynthetic process; ISO:RGD.
DR   GO; GO:0016125; P:sterol metabolic process; IMP:RGD.
DR   GO; GO:0016104; P:triterpenoid biosynthetic process; IEA:InterPro.
DR   CDD; cd02892; SQCY_1; 1.
DR   Gene3D; 1.50.10.20; -; 2.
DR   Gene3D; 6.20.120.20; -; 1.
DR   InterPro; IPR032696; SQ_cyclase_C.
DR   InterPro; IPR032697; SQ_cyclase_N.
DR   InterPro; IPR018333; Squalene_cyclase.
DR   InterPro; IPR002365; Terpene_synthase_CS.
DR   InterPro; IPR008930; Terpenoid_cyclase/PrenylTrfase.
DR   NCBIfam; TIGR01787; squalene_cyclas; 1.
DR   PANTHER; PTHR11764:SF20; LANOSTEROL SYNTHASE; 1.
DR   PANTHER; PTHR11764; TERPENE CYCLASE/MUTASE FAMILY MEMBER; 1.
DR   Pfam; PF13243; SQHop_cyclase_C; 1.
DR   Pfam; PF13249; SQHop_cyclase_N; 1.
DR   SFLD; SFLDG01016; Prenyltransferase_Like_2; 1.
DR   SUPFAM; SSF48239; Terpenoid cyclases/Protein prenyltransferases; 2.
DR   PROSITE; PS01074; TERPENE_SYNTHASES; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Direct protein sequencing; Endoplasmic reticulum; Isomerase;
KW   Lipid biosynthesis; Lipid metabolism; Membrane; Reference proteome; Repeat;
KW   Steroid biosynthesis.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P48449"
FT   CHAIN           2..733
FT                   /note="Lanosterol synthase"
FT                   /id="PRO_0000072661"
FT   REPEAT          125..166
FT                   /note="PFTB 1"
FT   REPEAT          484..529
FT                   /note="PFTB 2"
FT   REPEAT          561..601
FT                   /note="PFTB 3"
FT   REPEAT          613..654
FT                   /note="PFTB 4"
FT   ACT_SITE        456
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P48449"
FT   MOD_RES         2
FT                   /note="N-acetylthreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P48449"
FT   CONFLICT        139
FT                   /note="D -> N (in Ref. 1; AAA91023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        189
FT                   /note="A -> G (in Ref. 2; BAA08208)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        481
FT                   /note="R -> Q (in Ref. 2; BAA08208)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        486
FT                   /note="D -> N (in Ref. 2; BAA08208)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        557
FT                   /note="S -> I (in Ref. 1; AAA91023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        683
FT                   /note="L -> F (in Ref. 2; BAA08208)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        687
FT                   /note="D -> E (in Ref. 2; BAA08208)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   733 AA;  83301 MW;  3679C0259CBDF771 CRC64;
     MTEGTCLRRR GGPYKTEPAT DLTRWRLHNE LGRQRWTYYQ AEEDPGREQT GLEAHSLGLD
     TTSYFKNLPK AQTAHEGALN GVTFYAKLQA EDGHWAGDYG GPLFLLPGLL ITCHIAHIPL
     PAGYREEMVR YLRSVQLPDG GWGLHIEDKS TVFGTALSYV SLRILGIGPD DPDLVRARNI
     LHKKGGAVAI PSWGKFWLAV LNVYSWEGIN TLFPEMWLLP EWFPAHPSTL WCHCRQVYLP
     MSYCYATRLS ASEDPLVQSL RQELYVEDYA SIDWPAQKNN VCPDDMYTPH SWLLHVVYGL
     LNLYERFHST SLRKWAIQLL YEHVAADDRF TKCISIGPIS KTVNMLIRWS VDGPSSPAFQ
     EHVSRIKDYL WLGLDGMKMQ GTNGSQTWDT SFAVQALLEA GAHRRPEFLP CLQKAHEFLR
     LSQVPDNNPD YQKYYRHMHK GGFPFSTLDC GWIVADCTAE ALKAVLLLQE RCPSITEHVP
     RERLYDAVAV LLSMRNSDGG FATYETKRGG YLLELLNPSE VFGDIMIDYT YVECTSAVMQ
     ALRHFREYFP DHRATESRET LNQGLDFCRK KQRADGSWEG SWGVCFTYGT WFGLEAFACM
     GHIYQNRTAC AEVAQACHFL LSRQMADGGW GEDFESCEQR RYVQSAGSQV HSTCWALLGL
     MAVRHPDISA QERGIRCLLG KQLPNGDWPQ ENISGVFNKS CAISYTNYRN IFPIWALGRF
     SSLYPDNTLA GHI
//
